Qube Research & Technologies (QRT)’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Buy
134,224
+7,288
+6% +$536K 0.01% 1272
2025
Q4
$8.62M Buy
126,936
+34,939
+38% +$2.18M 0.01% 1442
2025
Q3
$5.25M Buy
91,997
+76,593
+497% +$4.54M 0.01% 1725
2025
Q2
$853K Sell
15,404
-70,465
-82% -$3.3M ﹤0.01% 2524
2025
Q1
$3.75M Buy
85,869
+29,081
+51% +$1.27M ﹤0.01% 1679
2024
Q4
$2.44M Buy
56,788
+14,074
+33% +$634K ﹤0.01% 1800
2024
Q3
$1.91M Buy
42,714
+15,835
+59% +$655K ﹤0.01% 1778
2024
Q2
$1.03M Sell
26,879
-25,576
-49% -$975K ﹤0.01% 1874
2024
Q1
$1.81M Buy
52,455
+50,413
+2,469% +$1.62M ﹤0.01% 1820
2023
Q4
$59.1K Sell
2,042
-8,355
-80% -$190K ﹤0.01% 3264
2023
Q3
$197K Buy
+10,397
New +$197K ﹤0.01% 2412

Other funds holding DBD

Qube Research & Technologies (QRT)'s DBD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Diebold Nixdorf (DBD) stake by 5.7% in Q1 2026, buying an estimated $536K and bringing the position to 134,224 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #1272.

Qube Research & Technologies (QRT) first reported a position in DBD in Q3 2023 and has held it in 11 quarters since. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • Qube Research & Technologies (QRT) held 134,224 shares of Diebold Nixdorf worth $10.1M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 7,288 Diebold Nixdorf shares in Q1 2026, an estimated $536K.
  • Diebold Nixdorf made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1272 holding.
  • Qube Research & Technologies (QRT) first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 11 quarters since.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.